|
|
|
|
|
|
|
calcium channel blockers (dihydropyridine) |
|
|
|
carbamates |
|
|
|
|
|
carbohydrates |
|
|
|
|
|
|
|
ccr5 co.receptor antagonists |
|
CD4-directed post-attachment HIV-1 inhibitor |
|
|
|
chloride channel activators |
|
|
|
|
|
cholinergics, muscarinic agonists, sialagogues |
|
|
|
cholinergics (cholinesterase inhibitors), n methyl d aspartate antagonist |
|
cholinesterase reactivators |
|
cortisol synthesis inhibitors |
|
coumarins |
|
cox 2 inhibitors |
|
cyclic lipopeptide antibacterial agents |
|
|
|
colloids |
|
complement.inhibitors |
|
complement.inhibitors, monoclonal antibodies |
